Page last updated: 2024-09-05

3'-galactosyllactose and Influenza, Human

3'-galactosyllactose has been researched along with Influenza, Human in 1 studies

*Influenza, Human: An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Braber, S; Cai, Y; Folkerts, G; Garssen, J; Hogenkamp, A; Kraneveld, AD; Leusink-Muis, T; Stahl, B; Tims, S; Toutounchi, NS; van Ark, I; Van't Land, B; Varasteh, S; Wehkamp, T; Wiertsema, S1

Other Studies

1 other study(ies) available for 3'-galactosyllactose and Influenza, Human

ArticleYear
Human Milk Oligosaccharide 3'-GL Improves Influenza-Specific Vaccination Responsiveness and Immunity after Deoxynivalenol Exposure in Preclinical Models.
    Nutrients, 2021, Sep-14, Volume: 13, Issue:9

    Topics: Adaptive Immunity; Animals; Caco-2 Cells; Cecum; Diet; Fatty Acids, Volatile; Female; Food Contamination; Humans; Influenza, Human; Intestines; Mice, Inbred C57BL; Milk, Human; Mycotoxins; Oligosaccharides; Spleen; Th1 Cells; Trichothecenes; Trisaccharides; Vaccination; Vaccines

2021